Why the study?
Global inflammation scores encompassing pro- and anti-inflammatory proteins and pathways may enhance risk assessment for cardiometabolic diseases and elucidate disease mechanisms.
Global inflammation scores (AIS and PCA) may provide new opportunities for cardiometabolic risk assessment.
Answers are grounded in this paper and cite their sources.
May refine cardiometabolic risk stratification; leaves open prospective validation before clinical adoption.
Global inflammation scores encompassing an array of pro- and anti-inflammatory proteins and pathways may enhance risk assessment for cardiometabolic diseases. The AIS and PCA scores provide further opportunities to investigate the mechanisms of inflammation-related risk of disease.
No takes yet. Share an insight, caveat, or question.
Tejada et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: